Canopy Growth (CGC) Cost of Revenue (2019 - 2025)
Canopy Growth's (CGC) quarterly Cost of Revenue came in at $38.1 million in Q4 2025, up 4.94% year-on-year from $36.3 million in Q4 2024, and up 16.97% quarter-over-quarter from $32.5 million in Q3 2025.
Canopy Growth (CGC) Cost of Revenue (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed Cost of Revenue across 7 years of filings, most recently posting $38.1 million for Q4 2025.
- Cost of Revenue for Q4 2025 came in at $38.1 million, up 4.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $147.6 million (up 5.03% YoY), and the FY2025 annual result was $132.1 million, down 17.72% from the prior year.
- Cost of Revenue came in at $38.1 million for Q4 2025 at Canopy Growth, up from $32.5 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $174.3 million in Q1 2022 to a low of $30.2 million in Q3 2024.
- The 5-year median for Cost of Revenue is $44.5 million (2023), against an average of $67.8 million.
- Across the five-year window, Cost of Revenue soared 96.35% in 2021 and slumped 57.8% in 2022, its largest moves.
- Canopy Growth's Cost of Revenue stood at $103.8 million in 2021, then tumbled by 43.51% to $58.7 million in 2022, then plunged by 37.04% to $36.9 million in 2023, then slipped by 1.8% to $36.3 million in 2024, then climbed by 4.94% to $38.1 million in 2025.
- The last three Cost of Revenue figures came in at $38.1 million (Q4 2025), $32.5 million (Q3 2025), and $39.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 696.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 641.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 133.40 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 34.44 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.80 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 586.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 155.56 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 52.68 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 222.00 Mn |
| 10 | Canopy Growth | 11.27 Mn | -137.42 Mn | 15.39 Mn | 38.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.06 Mn |
| Dec 31, 2025 | 38.06 Mn |
| Sep 30, 2025 | 32.54 Mn |
| Sep 30, 2025 | 32.54 Mn |
| Jun 30, 2025 | 39.04 Mn |
| Jun 30, 2025 | 39.04 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Dec 31, 2024 | 36.27 Mn |
| Dec 31, 2024 | 36.27 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Sep 30, 2024 | 30.17 Mn |
| Jun 30, 2024 | 31.57 Mn |
| Jun 30, 2024 | 31.57 Mn |
| Mar 31, 2024 | 42.54 Mn |
| Mar 31, 2024 | 42.54 Mn |
| Dec 31, 2023 | 36.93 Mn |
| Dec 31, 2023 | 36.93 Mn |
| Sep 30, 2023 | 34.44 Mn |
| Sep 30, 2023 | 34.44 Mn |